Your browser doesn't support javascript.
loading
A Phase 1/2 Study of the Oral Janus Kinase 1 Inhibitors INCB052793 and Itacitinib Alone or in Combination With Standard Therapies for Advanced Hematologic Malignancies.
Zeidan, Amer M; Cook, Rachel J; Bordoni, Rodolfo; Berenson, James R; Edenfield, William J; Mohan, Sanjay; Zhou, Gongfu; Asatiani, Ekaterine; Srinivas, Nithya; Savona, Michael R.
Afiliação
  • Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale University and Yale Cancer Center, New Haven, CT.
  • Cook RJ; Oregon Health & Science University, Portland, OR.
  • Bordoni R; Georgia Cancer Specialists, Marietta, GA.
  • Berenson JR; Berenson Oncology, West Hollywood, CA.
  • Edenfield WJ; Greenville Health System Cancer Institute, Greenville, SC.
  • Mohan S; Department of Internal Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
  • Zhou G; Incyte Corporation, Wilmington, DE.
  • Asatiani E; Incyte Corporation, Geneva, Switzerland.
  • Srinivas N; Incyte Corporation, Wilmington, DE.
  • Savona MR; Department of Internal Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN. Electronic address: michael.savona@vanderbilt.edu.
Clin Lymphoma Myeloma Leuk ; 22(7): 523-534, 2022 07.
Article em En | MEDLINE | ID: mdl-35260349

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Neoplasias Hematológicas / Inibidores de Janus Quinases Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Neoplasias Hematológicas / Inibidores de Janus Quinases Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article